Korean J Urol.  2008 Aug;49(8):715-719.

Lower Urinary Tract Symptoms after RadicalRetropubic Prostatectomy: Preliminary Study

• Choi HS
• Im CM
• Kim SO
• Kim MK
• Kwon DD
• Ryu SB

Abstract

PURPOSE: The primary objective of this study was to evaluate the impact of radical retropubic prostatectomy(RRP) on lower urinary tract symptoms(LUTS) in patients with clinically localized prostate cancer.
MATERIALS AND METHODS
Between 2000 and 2006, 82 men with clinically localized prostate cancer underwent RRP. The International Prostate Symptom Score(IPSS) and the IPSS quality of life(QoL) score, and uroflowmetry were administered both prior to and 1 year after RRP.
RESULTS
The overall mean total IPSS, maximal flow rate, and postvoid residual volume did not change over time after RRP. Prior to and after RRP, the mean maximal flow rate and residual urine changed from 17.6ml/sec to 17.9ml/sec(p=0.566) and 16.9ml to 15.8ml(p=0.777), respectively. Total IPSS also changed after RRP, from 12.8 to 12.5(p=0.731). The reduction of the IPSS was more prominent in patients with severe symptoms(IPSS> or =20), whereas in those with moderate symptoms(8< or =IPSS<20), the score did not change significantly after RRP. Furthermore, in those patients with no or mild symptoms(IPSS<8), the score increased after RRP.
CONCLUSIONS
RRP was not shown to improve uroflowmetric parameters, including maximal flow rate, postvoid residual urine, and IPSS, in cases of moderate LUTS. However, RRP may exert a beneficial effect in those patients with severe LUTS, and may also have adverse effects on some individuals with no or mild symptoms. We believe that these results might be utilized when counseling patients about treatment options for localized prostate cancer.

Keyword

Prostate cancer; Radical prostatectomy; Lower urinary tract symptoms

MeSH Terms

Counseling
Humans
Lower Urinary Tract Symptoms
Male
Prostate
Prostatic Neoplasms
Residual Volume
Urinary Tract

Reference

1. Lepor H. Raus SN, editor. Selecting candidates for radical prostatectomy. Urology annual. 1997. Norwalk: Appleton and Lange;1–13.

2. Catalona WJ, Han M. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Definitive therapy for localized prostate cancer-an overview. Campbell-Walsh urology. 2007. 9th ed. Philadelphia: Saunders;2932–2946.

3. Catalona WJ, Smith DS. 5 year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol. 1994. 152:1837–1842.

4. Leandri P, Rossignol G, Gautier JR, Ramon J. Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol. 1992. 147:883–887.

5. Graefen M, Haese A, Pichlmeier U, Hammerer PG, Noldus J, Butz K, et al. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol. 2001. 165:857–863.

6. Noldus J, Michl U, Graefen M, Haese A, Hammerer P, Huland H. Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy. Eur Urol. 2002. 42:118–124.

7. Catalona WJ, Ramos CG, Carvalhal GF. Contemporary results of anatomic radical prostatectomy. CA Cancer J Clin. 1999. 49:282–296.

8. Schwartz EJ, Lepor H. Radical retropubic prostatectomy reduces symptom scores and improves quality of life in man with moderate and severe lower urinary tract symptoms. J Urol. 1998. 161:1185–1188.

9. Hollenbeck BK, Lipp ER, Hayward RA, Montie JE, Schottenfeld D, Wei JT. Concurrent assessment of obstructive/irritative urinary symptoms and incontinence after radical prostatectomy. Urology. 2002. 59:389–393.

10. Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlén BJ, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002. 347:790–796.

11. Lepor H, Machi G. Comparison of AUA symptom index in unselected males and females between 55 and 79 years of age. Urology. 1993. 42:36–40.

12. Jung YS, Hwang TK, Kim JC. The outcome and satisfaction of patients with lower urinary tract symptoms/benign prostatic hyperplasia following transurethral resection of the prostate according to urodynamic obstruction and the bladder function. Korean J Urol. 2007. 48:965–970.

13. Namiki S, Saito S, Ishidoya S, Tochigi T, Ioritani N, Yoshimura K, et al. Adverse effect of radical prostatectomy on nocturia and voiding frequency symptoms. Urology. 2005. 66:147–151.

14. Yoshimura K, Ohara H, Ichioka K, Terada N, Matsui Y, Terai A, et al. Nocturia and benign prostatic hyperplasia. Urology. 2003. 61:786–790.

15. Joung JY, Park JK, Park CH, Lee JG, Chung BH, Hong SJ, et al. The role of alpha 1 (A) adrenoceptor antagonist tamsulosin for the treatment of patients with benign prostatic hyperplasia: the effect on lower urinary tract symptoms and nocturia. Korean J Urol. 2006. 47:1–6.

16. Gomha MA, Boone TB. Voiding patterns in patients with post-prostatectomy incontinence: urodynamic and demographic analysis. J Urol. 2003. 169:1766–1769.

17. Hellstrom P, Lukkarinen O, Kontturi M. Urodynamics in radical retropubic prostatectomy. Scand J Urol Nephrol. 1989. 23:21–24.

18. Jung SY, Fraser MO, Ozawa H, Yokoyama O, Yoshiyama M, De Groat WC, et al. Urethral afferent nerve activity affects the micturition reflex: implication for the relationship between stress incontinence and detrusor instability. J Urol. 1999. 162:204–212.

19. Kumar V, Toussi H, Marr C, Hough C, Javle P. The benefits of radical prostatectomy beyond cancer control in symptomatic men with prostate cancer. BJU Int. 2004. 93:507–509.

20. Namiki S, Ishidoya S, Saito S, Satoh M, Tochigi T, Ioritani N, et al. Natural history of voiding function after radical retropubic prostatectomy. Urology. 2006. 68:142–147.

21. Matsubara A, Yoneda T, Yasumoto H, Teishima J, Shiina H, Igawa M, et al. Lower urinary tract symptoms after radical perineal prostatectomy. Jpn J Clin Oncol. 2007. 37:534–539.

22. Sciarra A, D'eramo G, Casale P, Loreto A, Buscarini M, Nicola SD, et al. Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia. The Prostate. 1998. 34:121–128.

23. Vesely S, Knutson T, Damber JE, Dicuio M, Dahlstrand C. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. Scand J Urol Nephrol. 2003. 37:322–328.